BioRestorative Therapies, Inc.
BRTX
$2.74
-$0.06-2.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.83% | -5.57% | -14.38% | 50.25% | -226.37% |
| Total Depreciation and Amortization | -0.76% | 0.38% | -0.19% | 1.74% | 2.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -500.77% | 42.62% | -51.17% | -107.07% | 398.62% |
| Change in Net Operating Assets | -185.97% | 151.52% | 298.66% | 386.22% | -135.21% |
| Cash from Operations | -57.66% | 16.75% | -7.69% | 3.06% | -18.36% |
| Capital Expenditure | -- | -- | -- | 100.00% | -193.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.96% | 24.16% | -6.31% | -11.28% | 55.56% |
| Cash from Investing | -59.66% | 20.18% | -6.31% | -9.92% | 54.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -344.51% | -- | -- | -- |
| Issuance of Common Stock | 361.34% | -- | -100.00% | 68.44% | 89.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -290.78% | 16.51% | -337.24% | -16.67% | 95.34% |
| Cash from Financing | 381.02% | 1,972.62% | -105.55% | -18.72% | 965.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.24% | 195.37% | -391.82% | -52.05% | 172.31% |